Neurogene Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 925K |
| Cost of Goods Sold | 854K | 787K | 17.2M | 19.4M | 17.8M | 15.3M | 16.3M | 817K |
| Gross Profit | -854K | -787K | -17.2M | -19.4M | -17.8M | -15.3M | -16.3M | 108K |
| R&D Expenses | 25.1M | 20.6M | 17.2M | 19.4M | 17.8M | 15.3M | 16.3M | 15.7M |
| Operating Expenses | 32.5M | 26.7M | 6.6M | 6.7M | 8.2M | 6.2M | 5.9M | 20.2M |
| Operating Income | -33.3M | -27.5M | -23.8M | -26.1M | -25.9M | -21.5M | -22.2M | -20.1M |
| Other Income / Gains | 2.4M | 2.8M | 2.8M | 4.1M | 3.3M | 2.0M | 2.0M | 1.6M |
| Net Income | -30.9M | -24.7M | -21.0M | -22.0M | -22.6M | -19.5M | -20.2M | -18.5M |
| EPS (Diluted) | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 | -1.31 | -1.19 | -1.09 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.117 |
| General And Administrative Expenses | 8.2M | 0 | 6.6M | 6.7M | 8.2M | 6.2M | 5.9M | 5.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 8.2M | 6.1M | 6.6M | 6.7M | 8.2M | 6.2M | 5.9M | 5.3M |
| Other Expenses | -854K | 0 | -17.2M | -19.4M | -17.8M | -15.3M | -16.3M | -817K |
| Cost And Expenses | 33.3M | 27.5M | 23.8M | 26.1M | 25.9M | 21.5M | 22.2M | 21.1M |
| Interest Income | 2.3M | 2.7M | 2.7M | 2.9M | 3.2M | 2.3M | 1.8M | 2.0M |
| Interest Expense | 0 | 1K | 1K | 1K | 2K | 2K | 3K | 4K |
| Depreciation And Amortization | 854K | 787K | 776K | 767K | 762K | 798K | 807K | 817K |
| Ebitda | -30.1M | -23.9M | -20.2M | -21.2M | -21.9M | -18.7M | -19.4M | -17.7M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.104 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21.766 |
| Income Before Tax | -30.9M | -24.7M | -21.0M | -22.0M | -22.6M | -19.5M | -20.2M | -18.5M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.991 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.991 |
| Epsdiluted | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 | -1.31 | -1.19 | -1.09 |
| Weighted Average Shs Out | 22.3M | 15.5M | 21.2M | 21.1M | 21.0M | 14.9M | 17.0M | 16.9M |
| Weighted Average Shs Out Dil | 22.3M | 15.5M | 21.2M | 21.1M | 21.0M | 14.9M | 17.0M | 16.9M |